Centurion Acquisition Corp. (ALF)vsChurchill Capital Corp XI (CCXI)
ALF
Centurion Acquisition Corp.
$10.80
-0.83%
FINANCIAL SERVICES · Cap: $391.36M
CCXI
Churchill Capital Corp XI
$12.09
+0.33%
FINANCIAL SERVICES · Cap: $746.38M
Smart Verdict
WallStSmart Research — data-driven comparison
CCXI leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 23/100 (F).
ALF
Avoid21
out of 100
Grade: F
CCXI
Avoid23
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
0.0% revenue growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
0.0% margin — thin
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : ALF
ALF has a balanced fundamental profile.
Bull Case : CCXI
CCXI has a balanced fundamental profile.
Bear Case : ALF
The primary concerns for ALF are Revenue Growth, Market Cap, Return on Equity. A P/E of 41.9x leaves little room for execution misses.
Bear Case : CCXI
The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
CCXI is growing revenue faster at 0.0% — sustainability is the question.
ALF generates stronger free cash flow (-26,975), providing more financial flexibility.
Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CCXI scores higher overall (23/100 vs 21/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Centurion Acquisition Corp.
FINANCIAL SERVICES · SHELL COMPANIES · USA
Alfi, Inc. provides interactive intelligent artificial intelligence and machine learning software solutions. The company is headquartered in Miami Beach, Florida.
Churchill Capital Corp XI
FINANCIAL SERVICES · SHELL COMPANIES · USA
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
Compare with Other SHELL COMPANIES Stocks
Want to dig deeper into these stocks?